GENFIT Stock OTC Markets
Stocks
GNFTF
FR0004163111
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.75 USD | -2.18% |
|
-.--% | +79.17% |
| 07-03 | Genfit soars on news of U.S. reimbursement for a product |  |
| 07-03 | Genfit's Liver Disease Blood Test Approved for US Medicare Reimbursement | MT |
| Market Cap | 688M 785M 635M 587M 1.11B 75.14B 1.14B 7.64B 2.97B 36.77B 2.95B 2.88B 128B | P/E 2026 * |
72.4x | P/E 2027 * | 91.4x |
|---|---|---|---|---|---|
| Enterprise Value | 641M 731M 592M 547M 1.04B 70.03B 1.06B 7.12B 2.77B 34.27B 2.75B 2.69B 119B | EV / Sales 2026 * |
6.74x | EV / Sales 2027 * | 5.29x |
| Free-Float |
86.88% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -2.18% | ||
| 1 month | +13.16% | ||
| 3 months | +3.07% | ||
| 6 months | +79.17% | ||
| Current year | +79.17% |
| 1 month | 9.98 |  | 11.1 |
| Current year | 7.26 | | 11.1 |
| 1 year | 3.28 | | 11.1 |
| 3 years | 2.95 | | 11.1 |
| 5 years | 2.95 | | 11.1 |
| 10 years | 0 | | 36.86 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Prigent
CEO | Chief Executive Officer | 58 | 2019-09-15 |
Thomas Baetz
DFI | Director of Finance/CFO | 52 | 2021-04-21 |
Pejvack Motlagh
CTO | Chief Tech/Sci/R&D Officer | - | 2025-11-26 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 2017-06-15 | |
| Director/Board Member | 54 | 1999-09-14 | |
| Director/Board Member | 58 | 2017-06-15 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.18% | -.--% | - | - | 769M | |
| -0.24% | +4.98% | +2.69% | +9.14% | 49.74B | |
| -0.36% | +1.33% | +417.51% | +619.10% | 40.49B | |
| -2.29% | +5.93% | +25.27% | +59.26% | 34.35B | |
| -2.13% | +5.47% | +25.45% | -6.01% | 34.75B | |
| -0.79% | +2.02% | +3.83% | +36.42% | 26.98B | |
| +3.82% | +3.92% | - | - | 16.58B | |
| -2.62% | +0.45% | +66.82% | +125.87% | 15.6B | |
| -2.17% | +6.52% | +102.15% | +102.15% | 14.27B | |
| -2.70% | -2.19% | +11.25% | +18.19% | 13.76B | |
| Average | -1.17% | +3.99% | +81.87% | +120.52% | 27.39B | |
| Weighted average by Cap. | -1.00% | +4.37% | +93.71% | +139.18% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 95.2M 109M 87.89M 81.22M 154M 10.39B 157M 1.06B 411M 5.09B 408M 399M 17.65B | 119M 136M 110M 102M 193M 13.02B 197M 1.32B 514M 6.37B 511M 499M 22.12B |
| Net income | 18.63M 21.24M 17.2M 15.89M 30.12M 2.03B 30.73M 207M 80.33M 995M 79.76M 78.01M 3.45B | 33.33K 38K 30.77K 28.44K 53.9K 3.64M 54.97K 370K 144K 1.78M 143K 140K 6.18M |
| Net Debt | -46.87M -53.43M -43.27M -39.98M -75.79M -5.12B -77.3M -520M -202M -2.5B -201M -196M -8.69B | -56.87M -64.84M -52.51M -48.52M -91.97M -6.21B -93.81M -631M -245M -3.04B -244M -238M -10.55B |
| Date | Price | Change | Volume |
|---|
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GNFT Stock
- GNFTF Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
